Print

SCIVAC International Congress

The hottest questions on leishmaniasis

March 26-27, 2022
Online

PROGRAMME

First day - Saturday, March 26, 2022
8:30
Registration
9:45
Opening speech
9:50
Leishmania and social commitment: why are migrants not a problem for the import of new Leishmania zoonotic species?
D.Otranto, R.Iatta
10:30
New Leishmania: do we really know all the Leishmania in Italy? Could we “meet” others?
J.Mendoza-Roldan
11:10
Coffee break
11:40
Leishmaniasis in cats and other synanthropic/exotic animals. When is the cat a real problem for the epidemiology of leishmaniasis?
R.Iatta
12:20
I have a clinical suspicion of Leishmaniasis: which advice for a correct etiological diagnosis?
X.Roura
13:00
ANMVI report
13:30
Lunch break
14:30
My dog is positive to Leishmania. What test would you perform? IFI or ELISA? What tests should be done to assess the clinical condition of a dog with leishmaniasis?
W.Bertazzolo
15:10
Diagnosis and monitoring of leishmaniasis: when are molecular biology tests really necessary?
W.Bertazzolo
15:50
Leishmaniasis and co-infections: what are the diagnostic and therapeutic challenges in animals co-infected with pathogens transmitted by ticks and… not only by ticks?
G.Baneth
16:30
Coffee break
17:00
Corporate report by ELANCO
17:20
What is the most suitable therapy for leishmaniasis? Evidence in the scientific literature of antimonials vs miltefosine.
X.Roura
18:00
I have a dog with leishmaniasis and proteinuria: should I immediately start anti-proteinuric therapy or should I await the outcome of the therapy?
X.Roura
18:40
End of the Day
Second day - Sunday, March 27, 2022
9:00
The role of steroids in leishmaniasis therapy: when to use them and why?
X.Roura
9:40
How to monitor a patient with leishmaniasis? Electrophoresis? Antibody titer? PCR? Which test is most useful? How do I use these tests?
W.Bertazzolo
10:20
Coffee break
10:50
How can I diagnose periarthritis in leishmaniasis and other infectious diseases and how can I treat it?
F.Dondi
11:30
Corporate report by MSD
11:50
What is the pathogenesis of haematological and biochemical changes in leishmaniasis? When are they a problem for the patient?
G.Baneth
12:30
How can I best manage leishmaniasis therapy? Duration of therapy and complications. What are the clinical signs suggesting a relapse?
X.Roura
13:10
Lunch break
14:30
Allopurinol: is it really that harmless? How to assess any complications and how to manage chronic therapy
F.Dondi
15:10
Corporate report by ROYAL CANIN
15:30
Vaccination: would you recommend vaccinating dogs from Southern and Central Italy? And those of the North? What about other immunomodulatory therapies? What is the scientific evidence?
X.Roura
16:10
Coffee break
16:40
Do we protect our animals adequately? What do phlebotomus (sand flies) say?
D.Otranto
17:20
What is the best therapeutic approach for advanced leishmaniasis?
X.Roura
18:00
End of the Day